Bavarian Nordic gets 50 million euro EIB loan for Ebola vaccine

COPENHAGEN, May 12 (Reuters) - Bavarian Nordic has received a 50 million euro ($56 million) loan from the European Investment Bank (EIB) to help it develop a vaccine against Ebola, which has claimed 11,000 lives in a pandemic in Western Africa.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.